Forte, Fernando C.
HRN: 24-70-17 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/22/2024
CEFTRIAXONE 1G (VIAL)
03/22/2024
03/29/2024
IV
2g
OD
UGIB Prob Sec To BPUD
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes